Plantar Fasciitis, Pain, Foot Diseases
Conditions
Brief summary
The aim of this study is to investigate the effects of Low-Dye and Kinesio Taping on pain and function in individuals with plantar fasciitis.
Detailed description
Subject: In this study, the effects of Low-Dye Taping and Kinesio Taping (KT) on pain and function will be investigated in individuals with plantar fasciitis. There are studies on both Low-Dye banding and KT in the literature and they are popular applications recently. However, to the best of our knowledge, when we look at the Turkish and English literature, no study has been found comparing these two therapeutic massages in terms of pain, functionality and performance. Purpose: Plantar fasciitis (PF) is a clinical picture characterized by degeneration of the plantar fascia resulting from repetitive microtrauma to the plantar fascia causing an inflammatory reaction. It is one of the most common causes of heel pain in adults. The plantar fascia has a fundamental role in the biomechanics of the foot, supporting the medial longitudinal arch (MLA), distributing forces and stresses of the foot during gait or other loading conditions. Disorders in the musculoskeletal and somatosensory system in patients with plantar fasciitis may cause pain and decrease in functional capacity. Therefore, its purpose is; This study was planned to show the effectiveness of taping methods applied in addition to ESWT in individuals presenting with heel pain. Thanks to the findings to be obtained from our study, it is aimed to contribute to the literature with objective, evidence-based results in this field.
Interventions
After ESWT application, Low-Dye Taping will be applied 3 times, once a week.
After ESWT application, Kinesio Taping will be applied 3 times, once a week.
Extracoporeal shock wave, 2000 shots/time, once a week for 3 weeks, shock wave freqency: 10Hz, total energy: 166 mJ/mm2, Pressure 2.5 Bar
Sponsors
Study design
Eligibility
Inclusion criteria
* Individuals diagnosed with plantar fasciitis by a physician * Age between 18 and 30 years * Agree to participate in the study
Exclusion criteria
* Not having surgery * Disagree to participate in the study * Infection * Pregnancy * Tumor
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from baseline in Pain at 3 Session | Changes in the VAS scores of the three groups before the treatment | A visual analog scale (VAS) numbered 0-10 will be used in the assessment of pain. |
Countries
Turkey (Türkiye)